Vendor, Cleveland, OH
Arteriocyte, Inc.
UEI P997X1C88B47, CAGE 483B3
1 award and -$5,178 obligated between August 30, 2024 and August 30, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$5,178 |
Industries
NAICS on the awards, by dollars.
| Professional, Scientific, and Technical ServicesNAICS 541711 | -$5,178 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100201300020CDefinitive Contract, August 30, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | The Purpose of This Modification Is to Deobligate Funding in the Amount of $5,177.81 in Cancelling Funds from Clin 0001 (Line 9).NAICS 541711, PSC AN13 | -$5,178 |
- Places of performance
- District of Columbia
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards